Company
GlaxoSmithKline plc
Headquarters: Brentford, United Kingdom
Founded: December 2000
Employees: 90,096
CEO: Ms. Emma N. Walmsley
Market Cap
£61.60 Billion
GBP as of July 1, 2024
US$77.93 Billion
GlaxoSmithKline plc Categories
United Kingdom Healthcare Drug Manufacturers—GeneralUnited Kingdom Healthcare United Kingdom Drug Manufacturers—General
Company Description
GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
| AbbVie | $295.34 B |
| AstraZeneca | $236.45 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
GlaxoSmithKline plc has the following listings and related stock indices.
Stock: LSE: GSK wb_incandescent
Stock: BCBA: GSK wb_incandescent
Stock: NYSE: GSK wb_incandescent
Stock: FSX: GS7 wb_incandescent
Stock: OTC: GLAXF wb_incandescent
Stock: XETR: GS7 wb_incandescent
Stock: BMV: GSKN wb_incandescent
Product & Services
Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines
Key People
Jonathan Symonds (Chairperson) Emma Walmsley (CEO)
Financials
Revenue: GB£34.114 billion (2021)
Operating income: GB£6.201 billion (2021)
Net income: GB£5.096 billion (2021)
Total assets: GB£79.103 billion (2021)
Total equity: GB£21.342 billion (2021)